Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Inappropriate Sinus Tachycardia Registry
NCT05107635 · View on ClinicalTrials.gov ↗
Study Summary
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Conditions Studied
Interventions
- DEVICE AtriCure Commercially Available Devices
Study Locations (10)
California
- Stanford University — Palo Alto
- Sequoia Hospital — Redwood City
Florida
- University of Florida — Gainesville
- Sarasota Memorial Hospital — Sarasota
Kansas
- Kansas City Cardiac Arrhythmia Research — Kansas City
Maryland
- MedStar Health Research Institute — Hyattsville
Ohio
- The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital — Cincinnati
Texas
- Texas Cardiac Arrhythmia Research Foundation — Austin
Utah
- Intermountain Medical Center — Murray
Other
- Universitair Ziekenhuis Brussels — Brussels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05107635
The ClinicalTrials.gov registry entry for NCT05107635 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 13 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention — of which AtriCure Commercially Available Devices is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05107635 reports 10 study locations spanning 8 distinct geographic areas — top geographies include California, Florida, Kansas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05107635 about?
NCT05107635 is a clinical study titled "Inappropriate Sinus Tachycardia Registry". The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, obs...
What is the current status of trial NCT05107635?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-03-01. Estimated completion is 2027-01.
What conditions does trial NCT05107635 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05107635?
The interventions under investigation include: AtriCure Commercially Available Devices (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05107635?
This trial is sponsored by AtriCure, which has 13 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05107635 being conducted?
This trial has 10 study locations across California, Florida, Kansas, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.